Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
Integrated Research (ITI) and Objective Corporation (OCL) lost their A1 Skaffold Scores overnight. Macquarie Telecom (MAQ), Resource Equipment (RQL) and Coventry Group (CYG) fell from A2 to A3, and Blue Sky Alternative Investments (BLA) and Pro Medicus (PME) from A2 to A4. Yesterday 87 companies achieved Skaffold’s A2 Score for quality and performance. Today that number stands at 82.